Search research articles
Contact Us
Filters
Showing results (161-170 of 165) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 165 results.
Proteomics
|
October 17, 2008
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density
Fei-Yan Deng, Yao-Zhong Liu, Li-Ming Li, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
David J Augeri, Jeffrey A Robl, David A Betebenner, et al.
Journal of Medicinal Chemistry
|
April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors
David R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Psychoradiology
|
April 26, 2024
A brain structural connectivity biomarker for autism spectrum disorder diagnosis in early childhood
Xi Jiang, Xiao-Jing Shou, Zhongbo Zhao, et al.
Journal of Medicinal Chemistry
|
September 11, 2014
Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119
Dean A Wacker, Ying Wang, Matthias Broekema, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 165) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 165 results.
Proteomics
|
October 17, 2008
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density
Fei-Yan Deng, Yao-Zhong Liu, Li-Ming Li, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
David J Augeri, Jeffrey A Robl, David A Betebenner, et al.
Journal of Medicinal Chemistry
|
April 30, 2004
Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors
David R Magnin, Jeffrey A Robl, Richard B Sulsky, et al.
Psychoradiology
|
April 26, 2024
A brain structural connectivity biomarker for autism spectrum disorder diagnosis in early childhood
Xi Jiang, Xiao-Jing Shou, Zhongbo Zhao, et al.
Journal of Medicinal Chemistry
|
September 11, 2014
Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119
Dean A Wacker, Ying Wang, Matthias Broekema, et al.
Page
of 17